SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001683168-20-000173
Filing Date
2020-01-16
Accepted
2020-01-16 16:41:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT 1 neurobo_sch13d.htm SC 13D/A 34635
  Complete submission text file 0001683168-20-000173.txt   36273
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
NeuroBo Pharmaceuticals, Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89598 | Film No.: 20531486
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 HUNTINGTON AVENUE BOSTON MA 02115
Business Address 177 HUNTINGTON AVENUE BOSTON MA 02115 774-289-9333
NEUROBO THERAPEUTICS, INC. (Filed by) CIK: 0001784036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A